Biblio
“Genetic association between endothelial nitric oxide synthase and Alzheimer disease.”, Clin Genet, vol. 70, no. 1, pp. 49-56, 2006.
, “Exceptional memory performance in the Long Life Family Study.”, Neurobiol Aging, vol. 34, no. 11, pp. 2445-8, 2013.
, “Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 1, pp. 35-43, 2009.
, “Overview and findings from the religious orders study.”, Curr Alzheimer Res, vol. 9, no. 6, pp. 628-45, 2012.
, “Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.”, Dement Geriatr Cogn Disord, vol. 45, no. 1-2, pp. 1-17, 2018.
, “Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.”, Neuromolecular Med, vol. 5, no. 2, pp. 133-46, 2004.
, “Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.”, Nat Genet, vol. 41, no. 2, pp. 192-8, 2009.
, “A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.”, JAMA Neurol, vol. 72, no. 4, pp. 414-22, 2015.
, “Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.”, Alzheimers Dement, vol. 13, no. 12, pp. 1410-1413, 2017.
, “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.”, Nature, vol. 505, no. 7484, pp. 550-554, 2014.
, “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.
, “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.
, “A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.”, Alzheimers Res Ther, vol. 11, no. 1, p. 71, 2019.
, “A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.”, Neurobiol Aging, vol. 37, pp. 208.e1-208.e9, 2016.
, “Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.”, PLoS Med, vol. 14, no. 3, p. e1002258, 2017.
, “Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.”, Mol Psychiatry, vol. 20, no. 12, pp. 1588-95, 2015.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.”, Alzheimers Dement, vol. 12, no. 2, pp. 121-129, 2016.
, “Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.”, Neurogenetics, vol. 11, no. 3, pp. 335-48, 2010.
, “SORL1 variants across Alzheimer's disease European American cohorts.”, Eur J Hum Genet, vol. 24, no. 12, pp. 1828-1830, 2016.
, “Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.”, PLoS Genet, vol. 13, no. 11, p. e1007045, 2017.
, “Genetic association of low density lipoprotein receptor and Alzheimer's disease.”, Neurobiol Aging, vol. 26, no. 1, pp. 1-7, 2005.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, , “Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 429-35, 2011.
,